News About: Pharm. Industry
Korean pharmaceutical firms urged to brace for diverse R&D investment portfolios
Amid depressed consumer demand and a slumping economy, Korean pharmaceutical firms plan to focus on a wide variety of R&D new drug projects, including first-generic version, bioequivalence-tested drugs and novel dosag...
Hepsera showing greater choice of therapeutic optionsLocal studies have shown that GSK's novel nucleotide analogue Hepsera (adefovir dipivoxil; ADV), which was launched in February in Korea, is effective in a broad range of patien...
|
CJ aims to expand anti-hangover drink sales
CJ Corporation said on May 18 that it has launched a new anti-hangover drink Condition ADH (Activator Decreasing Hangover) Project, which was jointly developed by CJ Food Research Institute and Japan's Maruzen Lab., t...
Domestic wholesaling industry mired in business slump
Korean drug wholesalers are struggling to bottom out the protracted business recession, but sluggish OTC sales and spate of bankruptcies cast a doubt over their outlook, industry sources said recently.
The overcro...
Daewoong Pharm: 25% dividends in the stockholder's meeting.
Daewoong Pharmaceutical Co. (President: Yoon Jae-seung) decided to give 25% dividends (625 won per a common stock) in the 2nd general stockholder's meeting at the auditorium of Daewoong's office, Samsung dong Seoul, o...
Daewoong stock-holding co. elected Mr. Jung Nan-young as president.
Daewoong took the 44th general stockholder's meeting on May 28 at the auditorium of Samsung dong office, and elected Mr. Jung Nan-young as the pesident of company and Prof. Jung Ki-taek of Kyunghee Univ. Graduate Scho...
Slow in OTC drug business worsen management hardship.
The management performance of the listed drug makers having a fiscal year ended in March was remarkably depressed largely stemming from poor sale performances of the non-prescription drugs.
According to Yakup Press...
AstraZeneca's Crestor to challenge Pfizer's Lipitor In Korea
AstraZeneca's Crestor (rosuvastatin), which is expected to be launched during the first half of this year, will race to catch up Korea's market share, posing a threat to Pifzer's Lipitor (atorvastatin) in the antihype...
Pharmaceutical equipment traders struggle to gain foothold in drug-related printing machine market
With impending implementation of a new drug identification system, a number of pharmaceutical equipment traders and manufacturers are moving to accelerate their bid to grasp initiatives in the drug-related printing ma...
First-quarter sales portion of flagship products in increasing trend
In the first quarter of this year, the combined sales record of leading items of 21 pharmaceutical firms, which are listed in Korea Stock Exchange and KOSDAQ market, posted 134.3 billion won, up 11.7 percent com...
